EUROPEAN HEART JOURNAL Journal
Overview
publication venue for
- Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial 2024
- Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial 2023
- Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial 2022
- Efficacy of ertugliflozin on hospitalisation for heart failure across the distribution of pre-trial ejection fraction: post hoc analyses of the VERTIS CV trial 2022
- Paroxysmal atrial fibrillation ablation with a novel flexible tip radiofrequency catheter incorporating contact force sensing: acute results of the TactiFlex AF IDE trial 2022
- Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial 2021
- Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial 2021
- Mediators of the effect of ertugliflozin on a composite kidney outcome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: analyses from VERTIS CV 2021
- 10-year trend analysis of in-hospital cardiac arrest: 2008-2017 United State hospitalizations 2020
- Positive clinical benefit on patient care, quality of life and symptoms after radiofrequency ablation with contact force in persistent atrial fibrillation: analyses from PRECEPT 2020
- The in-hospital outcomes of the use of microaxial left ventricular assist device vs intra-aortic ballon pump in acute myocardial infarction complicated by cardiogenic shock 2020
- Essential thrombocytosis is associated with worse hospital outcomes in patients presented with acute myocardial infarction: a propensity score analysis of the National Inpatient Sample 2019
- Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. 40:2801-2809. 2019
- Separate and combined associations of obesity andmetabolic health with coronary heart disease: a pan-European case-cohort analysis. 39:397-+. 2018
- Risk of major cardiovascular events in patients with type 2 diabetes with and without prior cardiovascular events: results from the LEADER trial 2017
- Baroreflex activation therapy improves status of resistant hypertension patients with heart failure 2014
- Effect of the polymer-based, pactitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. 28:1574-1582. 2007
Research
category
- CARDIAC & CARDIOVASCULAR SYSTEMS Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 0195-668X
Electronic International Standard Serial Number (EISSN)
- 1522-9645
Other
journal abbreviation
- EUR HEART J